ARCA Hero Image
Investor Relations

Press Releases

[+view all]
09.16.2021
ARCA biopharma Announces Enrollment of First International Patient in Phase 2b Clinical Trial Evaluating rNAPc2 as a Potential Treatment for COVID-19
08.16.2021
ARCA biopharma to Present at the Q3 Virtual Investor Summit on August 18th
08.09.2021
ARCA biopharma Announces Submission of PCT Patent Application for the Treatment of Coronavirus Infection and Associated Coagulopathy with rNAPc2
Investor Relations

Press Releases

[+view all]
09.16.2021
ARCA biopharma Announces Enrollment of First International Patient in Phase 2b Clinical Trial Evaluating rNAPc2 as a Potential Treatment for COVID-19
08.16.2021
ARCA biopharma to Present at the Q3 Virtual Investor Summit on August 18th
08.09.2021
ARCA biopharma Announces Submission of PCT Patent Application for the Treatment of Coronavirus Infection and Associated Coagulopathy with rNAPc2
ir-presentations
Presentations
[GO]
ir-reports
Annual Financial Reports
[GO]
ir-filings
SEC Filings
[GO]
ir-faq
Frequently Asked Questions
[GO]
ir-corp-gov

Corporate Governance

Committee Charters

PDF Icon
Audit Committee
PDF Icon
Compensation Committee
PDF Icon
Nominating & Governance Committee

Governance Documents

PDF Icon
Board of Directors Corporate Governance Principles
PDF Icon
ARCA biopharma, Inc. Code of Business Conduct and Ethics
PDF Icon
ARCA biopharma, Inc. Complaint and Investigation Policy and Procedure
PDF Icon
Contact the Board
Chairperson
Member
Chairperson
Member
Audit Committee
Compensation Committee
Nominating & Governance Committee
Raymond L. Woosley, M.D., Ph.D.
Member
Chairperson
Linda Grais, M.D.
Member
Chairperson
Robert E. Conway
Chairperson
Member
Dan Mitchell
Member
Member
Anders Hove, M.D.
Member